Showing results (61-70 of 259) with videos related to
Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248Steven P Treon, Zachary R Hunter, Jeffrey Matous, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)Steven P Treon, Kirsten Meid, Christina Tripsas, et al.British Journal of Haematology|February 28, 2020
Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemiaCristina Jiménez, Gloria G Chan, Lian Xu, et al.Molecular Cancer Therapeutics|January 17, 2012
Molecular and cellular effects of NEDD8-activating enzyme inhibition in myelomaDouglas W McMillin, Hannah M Jacobs, Jake E Delmore, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström MacroglobulinemiaSteven P Treon, Kirsten Meid, Joshua Gustine, et al.American Journal of Hematology|November 23, 2022
Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemiaJorge J Castillo, Christian Buske, Judith Trotman, et al.Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Bortezomib as a treatment option in patients with Waldenström macroglobulinemiaMeletios A Dimopoulos, Christine Chen, Efstathios Kastritis, et al.Investigative Ophthalmology & Visual Science|March 11, 2008
Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemiaMarcel N Menke, Gilbert T Feke, J Wallace McMeel, et al.Clinical Lymphoma, Myeloma & Leukemia|May 14, 2013
Challenges with serum protein electrophoresis in assessing progression and clinical response in patients with Waldenström macroglobulinemiaSacha N Uljon, Steven P Treon, Christina K Tripsas, et al.Clinical Lymphoma & Myeloma|April 14, 2009
Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemiaMarcel N Menke, Gilbert T Feke, J Wallace McMeel, et al.Pageof 26